Statins Lower Dementia Risk 15% in Diabetes Patients

People living with type 2 diabetes just got some genuinely hopeful news about their long-term brain health.

Researchers in Denmark tracked more than 132,000 people with type 2 diabetes for seven years and discovered something encouraging. Those who started taking statins within a year of their diagnosis had a 15 percent lower risk of developing dementia over the next decade.

Statins are cholesterol-lowering drugs already widely prescribed to people with diabetes to protect their hearts. Now it appears these same medications might be doing double duty by protecting the brain too.

Dr. Shoaib Afzal, chief physician at Herlev and Gentofte Hospital and study co-author, notes that many people who could benefit from statins aren't taking them. Between 50 and 75 percent of patients who should be on the medication according to clinical guidelines aren't receiving it.

The study, published in The Lancet Regional Health, followed patients diagnosed with type 2 diabetes between 2006 and 2019. Even those who started statins later, between one and five years after diagnosis, still saw a 10 percent reduction in dementia risk.

The connection makes sense when you understand how diabetes and dementia relate. People with type 2 diabetes develop dementia at higher rates than the general population, making prevention strategies especially important for this group.

Statins appear to work their brain-protecting magic in several ways. They create protective effects in the blood vessels of the brain and reduce stroke risk, which is itself a major dementia risk factor. They also lower heart attack risk, another condition linked to cognitive decline.

The Bright Side

Dr. Clifford Segil, a neurologist at Providence Saint John's Health Center, points out that statins seem particularly effective against vascular dementia, the subtype caused by reduced blood flow to the brain. The same healthy habits that prevent strokes and heart attacks also prevent this form of dementia.

Nobody should start taking statins solely to prevent dementia. But for the millions of people with type 2 diabetes who already need these medications for heart health, the brain benefits are a welcome bonus.

The timing matters too. Starting statins early in your diabetes journey appears to provide the most protection, giving your brain years of extra safeguarding against cognitive decline.

This research offers real hope for people navigating a type 2 diabetes diagnosis, transforming a necessary heart medication into a potential shield for future brain health.